- Home
- CJET vs GRCE Comparison
CJET vs GRCE Comparison
Compare CJET & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CJET
- GRCE
- Stock Information
- Founded
- CJET 2009
- GRCE 2002
- Country
- CJET China
- GRCE United States
- Employees
- CJET N/A
- GRCE N/A
- Industry
- CJET Auto Manufacturing
- GRCE
- Sector
- CJET Consumer Discretionary
- GRCE
- Exchange
- CJET Nasdaq
- GRCE NYSE
- Market Cap
- CJET 50.7M
- GRCE 42.1M
- IPO Year
- CJET N/A
- GRCE N/A
- Fundamental
- Price
- CJET $2.18
- GRCE $2.94
- Analyst Decision
- CJET
- GRCE Strong Buy
- Analyst Count
- CJET 0
- GRCE 1
- Target Price
- CJET N/A
- GRCE $12.00
- AVG Volume (30 Days)
- CJET 5.9K
- GRCE 53.8K
- Earning Date
- CJET 07-07-2025
- GRCE 06-23-2025
- Dividend Yield
- CJET N/A
- GRCE N/A
- EPS Growth
- CJET N/A
- GRCE N/A
- EPS
- CJET N/A
- GRCE N/A
- Revenue
- CJET $6,915,000.00
- GRCE N/A
- Revenue This Year
- CJET N/A
- GRCE N/A
- Revenue Next Year
- CJET N/A
- GRCE N/A
- P/E Ratio
- CJET N/A
- GRCE N/A
- Revenue Growth
- CJET N/A
- GRCE N/A
- 52 Week Low
- CJET $1.09
- GRCE $1.75
- 52 Week High
- CJET $15.78
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- CJET 67.12
- GRCE N/A
- Support Level
- CJET $1.44
- GRCE N/A
- Resistance Level
- CJET $2.18
- GRCE N/A
- Average True Range (ATR)
- CJET 0.12
- GRCE 0.00
- MACD
- CJET 0.06
- GRCE 0.00
- Stochastic Oscillator
- CJET 97.37
- GRCE 0.00
About CJET Chijet Motor Company Inc.
Chijet Motor Co Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.